Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Nisshin Seifun Group Inc. ( (JP:2002) ) is now available.
Nisshin Seifun Group Inc. is restructuring its business portfolio to align with its Medium-Term Management Plan 2026, aiming for sustainable growth. As part of this restructuring, Nisshin Pharma will cease its fine chemicals business and transfer its healthcare foods business to Oriental Yeast Co., Ltd., which is expected to enhance the healthcare foods segment. This move is driven by a challenging business environment for Nisshin Pharma’s fine chemicals and aims to leverage Oriental Yeast’s capabilities in food materials. The restructuring will result in an extraordinary loss of 2,276 million yen, impacting the company’s financial results.
More about Nisshin Seifun Group Inc.
Nisshin Seifun Group Inc. operates in the food and chemical industries, focusing on flour milling, healthcare foods, and fine chemicals. It is known for its research capabilities and high-quality standards, with a market focus on healthcare supplements and active pharmaceutical ingredients.
Average Trading Volume: 949,170
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen519.7B
For a thorough assessment of 2002 stock, go to TipRanks’ Stock Analysis page.